01 January 2000
Swedish adjustable gastric band (SAGB) implanted laparoscopically in the treatment of morbid obesity - the first experience in Poland
Mariusz Wyleżoł, Marian Pardela, Marek Gluck, Jacek Puzio, Jerzy CzaplaMed Sci Monit 2000; 6(3): SR441-445 :: ID: 421165
Abstract
Surgical treatment of morbid obesity is a recognized method of proceedingsin patients who did not obtain any positive results in conservative therapy. In October and November1998 laparoscopic implantation of the SAGB was performed among ten morbid obesity patients with meanBMI of 41.9 ± 3.6 kg/m2. It was the first experience in Poland. In this group we observed also non-insulindependent diabetes mellitus in five, hyperlipidemia in eight and hypertension in three patients. In thisseries, there was no mortality and no perioperative morbidity. The mean operation time was 158 +/- 51min. The mean hospital stay was four days after the operation. Median BMI reduction after four monthswas 4.7 ±1.6 kg/m2. Parallel to the reduction in body weight, there occurred a significant reductionin plasma concentration of glucose (111.0 ± 38.5 vs. 90.2 ± 20.8 p < 0.01), total cholesterol (223.8+/- 42.0 vs. 192.7 ± 21.3 p < 0.005), and LDL-cholesterol (140.4 ± 34.0 vs. 121.7 ±25.2 p < 0.01).Hypertension was still observed only in one patient. Nowadays laparoscopic gastric banding representsthe least invasive surgical treatment of morbid obesity. In our series laparoscopic implantation of SAGBseems to be an effective surgical method for the treatment of obesity. Substantial reduction in bodyweight was associated with improvement in metabolic control. Absence of mortality and morbidity is oneof the main aims in bariatric surgery which was achieved in our study. The results of the present, firstin Poland, preliminary study confirm previous observations that gastric banding is an effective treatmentof obesity.
Keywords: Blood Glucose, Body Mass Index, Cholesterol, Comorbidity, Diabetes Mellitus, Diabetes Mellitus, Type 2, Follow-Up Studies, Hypercholesterolemia, hyperlipidemia, Hypertension, Laparoscopy, Lipoproteins, LDL Cholesterol, Obesity, Obesity, Morbid, Poland, Prosthesis Design, Prosthesis Implantation, Stomach, Triglycerides, Weight Loss
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952